RBM15 and endometrium adenocarcinoma: We found that METTL3 and FTO mRNA expression was evidently decreased in endometrial adenocarcinoma while RBM15 mRNA expression was increased with no changes in YTHDF1 expression in cases versus controls (Figure 3G).